Farther Finance Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5K | Sell |
245
-186
| -43% | -$10.2K | ﹤0.01% | 2908 |
|
|
2025
Q1 | $29.3K | Buy |
431
+211
| +96% | +$14.3K | ﹤0.01% | 2169 |
|
|
2024
Q4 | $14.5K | Buy |
220
+130
| +144% | +$8.55K | ﹤0.01% | 2217 |
|
|
2024
Q3 | $6.33K | Buy |
90
+2
| +2% | +$141 | ﹤0.01% | 2550 |
|
|
2024
Q2 | $7.23K | Sell |
88
-38
| -30% | -$3.12K | ﹤0.01% | 2213 |
|
|
2024
Q1 | $11K | Sell |
126
-22
| -15% | -$1.92K | ﹤0.01% | 1724 |
|
|
2023
Q4 | $14.3K | Buy |
148
+112
| +311% | +$10.8K | ﹤0.01% | 1453 |
|
|
2023
Q3 | $3.19K | Sell |
36
-9
| -20% | -$796 | ﹤0.01% | 1673 |
|
|
2023
Q2 | $3.9K | Buy |
45
+34
| +309% | +$2.95K | ﹤0.01% | 1521 |
|
|
2023
Q1 | $1.07K | Hold |
11
| – | – | ﹤0.01% | 1827 |
|
|
2022
Q4 | $1.14K | Buy |
+11
| New | +$1.14K | ﹤0.01% | 1619 |
|